DOC
stock Real Estate REIT - Healthcare FacilitiesOverall Concerning · 28%
- Fundamentals Weak
- Trajectory Steady
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Bullish 5 of 5 trend signals bullishRSI 54 — momentum is balanced between buyers and sellers.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $19.09
- -1.88%
- Close
- $19.09
- -1.88%
- Current
- $19.09
- Prev close
- $19.45
- Today
- 4.10M
- 3-mo avg
- 8.98M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 577 days ago
- Next expected
- Jul 23in 2 days
Recent earnings dates
- May 5 77 days ago
- Feb 2 169 days ago
- Oct 23, 2025 271 days ago
- Jul 24, 2025 362 days ago
Past earnings dates come from DOC’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), DOC’s fundamentals read as weak overall.
At 59.6x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 6.4% yield is high; it is worth checking the payout is covered by profit.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 11.8% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 1.0% return on equity is weak; owners' capital is barely being put to work.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 0.4% return on assets is low; the asset base is generating little profit.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 1.60, the company carries a moderate, manageable amount of debt.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
This company does not report a current-assets breakdown, so the ratio cannot be computed.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 6.2% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 70.7% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $471.3M | $494.9M | $527.4M | $568.5M | $604.0M |
| Net income | $505.5M | $500.4M | $306.0M | $243.1M | $71.3M |
| Diluted EPS | $0.93 | $0.92 | $0.56 | $0.36 | $0.10 |
| Dividend / share | $1.20 | $1.20 | $1.20 | $1.20 | $1.22 |
| Total assets | $15.3B | $15.8B | $15.7B | $19.9B | $20.3B |
| Total liabilities | $8.1B | $8.5B | $8.8B | $10.9B | $12.0B |
| Shareholder equity | $7.1B | $7.2B | $6.9B | $8.4B | $7.5B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $140.9M | $142.8M | $146.0M | $148.9M | $148.9M | $150.5M | $155.7M | $200.3M |
| Net income | $146.0M | $85.9M | $4.5M | $42.8M | $31.7M | -$117.1M | $114.0M | $193.6M |
| Diluted EPS | $0.21 | $0.12 | $0.02 | $0.06 | $0.05 | $-0.17 | $0.16 | $0.28 |
| Dividend / share | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.31 | $0.30 |
Leadershipsynced from SEC 57d ago
- Brinker Scott M President and CEO · Director
- Bohn Scott R CDO and Head of Lab
- Cartwright Brian G. Director
- Ccrc Propco Ventures, Llc Director
- Connor James B. Director
- Griffin R Kent Jr Director
- Healthpeak Properties, Inc. Director
- Janus Member, Llc Director
- Lewis Sara Grootwassink Director
- Lias-Booker Ava Director
- Sandstrom Katherine M Director
- Weiss Richard A. Director
Officers and board are drawn from DOC’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- May 6 +18.1% one-day move
- Dec 31, 2025 FY2025 net income −71% YoY
- Dec 8, 2025 New 6-month low (-14% off peak)
- Oct 28, 2025 −5.4% one-day move
- Aug 1, 2025 New 6-month low (-19% off peak)
- Jul 25, 2025 −6.7% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $1.22
- 2026 so far
- $0.515 payments
- 2026 projected
- $1.22+0.1% vs 2025
Projection scales DOC’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- May 18 $0.10
- Apr 17 $0.10
- Mar 17 $0.10
- Feb 13 $0.10
- Jan 16 $0.10
- Dec 19, 2025 $0.10
- Nov 14, 2025 $0.10
- Oct 17, 2025 $0.10
- Sep 19, 2025 $0.10
- Aug 18, 2025 $0.10
- Jul 18, 2025 $0.10
- Jun 16, 2025 $0.10
- May 19, 2025 $0.10
- Apr 17, 2025 $0.10
- Feb 14, 2025 $0.30
- Nov 4, 2024 $0.30
- Aug 5, 2024 $0.30
- May 3, 2024 $0.30
- Feb 13, 2024 $0.30
- Nov 6, 2023 $0.30
- Aug 4, 2023 $0.30
- May 5, 2023 $0.30
- Feb 8, 2023 $0.30
- Nov 4, 2022 $0.30
- Aug 5, 2022 $0.30
- May 6, 2022 $0.30
- Feb 10, 2022 $0.30
- Nov 5, 2021 $0.30
- Aug 6, 2021 $0.30
Recent SEC filingssynced from SEC 51d ago
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report